Dongguang Chemical Limited
HKEX:1702.HK
1.92 (HKD) • At close July 31, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,920.711 | 3,130.781 | 2,880.934 | 1,956.044 | 2,121.592 | 2,285.619 | 1,858.955 | 1,457.523 | 1,859.3 | 1,383.882 |
| Cost of Revenue
| 2,587.75 | 2,801.167 | 2,422.121 | 1,721.395 | 1,806.179 | 1,992.983 | 1,668.744 | 1,307.769 | 1,406.321 | 1,150.26 |
| Gross Profit
| 332.961 | 329.614 | 458.813 | 234.649 | 315.413 | 292.636 | 190.211 | 149.754 | 452.979 | 233.622 |
| Gross Profit Ratio
| 0.114 | 0.105 | 0.159 | 0.12 | 0.149 | 0.128 | 0.102 | 0.103 | 0.244 | 0.169 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 73.994 | 53.204 | 63.965 | 57.18 | 61.44 | 78.331 | 67.182 | 49.264 | 62.675 | 43.093 |
| Selling & Marketing Expenses
| 4.077 | 3.634 | 3.328 | 3.202 | 2.794 | 2.339 | 4.078 | 2.075 | 25.84 | 23.262 |
| SG&A
| 78.071 | 56.838 | 67.293 | 60.382 | 64.234 | 80.67 | 71.26 | 51.339 | 88.515 | 66.355 |
| Other Expenses
| 5.061 | -0.951 | -3.571 | -4.075 | -6.253 | 0.902 | -4.029 | -1.344 | -6.947 | -4.381 |
| Operating Expenses
| 71.555 | 55.887 | 63.722 | 56.307 | 57.981 | 77.335 | 67.231 | 42.241 | 81.568 | 61.974 |
| Operating Income
| 254.89 | 277.73 | 404.124 | 182.005 | 253.597 | 219.59 | 71.431 | 29.557 | 238.979 | 119.135 |
| Operating Income Ratio
| 0.087 | 0.089 | 0.14 | 0.093 | 0.12 | 0.096 | 0.038 | 0.02 | 0.129 | 0.086 |
| Total Other Income Expenses Net
| 13.753 | -1.504 | -19.47 | -10.516 | -33.432 | -53.784 | -60.77 | -59.42 | -149.491 | -54.46 |
| Income Before Tax
| 268.643 | 276.226 | 384.654 | 171.489 | 220.165 | 165.806 | 71.431 | 36.914 | 208.462 | 119.135 |
| Income Before Tax Ratio
| 0.092 | 0.088 | 0.134 | 0.088 | 0.104 | 0.073 | 0.038 | 0.025 | 0.112 | 0.086 |
| Income Tax Expense
| 74.536 | 74.087 | 109.072 | 45.004 | 58.612 | 66.142 | 24.548 | 18.104 | 100.367 | 29.95 |
| Net Income
| 190.08 | 194.38 | 266.081 | 125.276 | 161.553 | 99.664 | 46.883 | 18.81 | 108.095 | 89.185 |
| Net Income Ratio
| 0.065 | 0.062 | 0.092 | 0.064 | 0.076 | 0.044 | 0.025 | 0.013 | 0.058 | 0.064 |
| EPS
| 0.31 | 0.31 | 0.43 | 0.2 | 0.26 | 0.16 | 0.087 | 0.041 | 0.23 | 0.19 |
| EPS Diluted
| 0.31 | 0.31 | 0.43 | 0.2 | 0.26 | 0.16 | 0.087 | 0.041 | 0.23 | 0.19 |
| EBITDA
| 404.862 | 411.954 | 566.682 | 345.025 | 408.177 | 370.871 | 277.524 | 239.555 | 497.652 | 270.655 |
| EBITDA Ratio
| 0.139 | 0.132 | 0.197 | 0.176 | 0.192 | 0.162 | 0.149 | 0.164 | 0.268 | 0.196 |